Effects of Foam Rolling on Plantar Flexor Recovery in Healthy Individuals
Effects of Foam Rolling Application on the Recovery of Musculotendinous Properties and Functional Parameters of Plantar Flexors in Healthy Individuals
1 other identifier
interventional
28
1 country
1
Brief Summary
Foam rolling (FR) is a self-myofascial release technique that involves using body weight to apply pressure to soft tissues through a foam roller. This technique has been widely used in rehabilitation and physical training settings, aiming at the treatment of myofascial dysfunctions, enhancement of physical performance, and recovery from exercise-induced muscle damage (EIMD). EIMD occurs following the performance of intense exercise, resulting in increased muscle stiffness and delayed onset muscle soreness (DOMS), as well as reductions in force production and range of motion (ROM). However, few studies have investigated the effects of FR on the recovery of musculotendinous and functional properties. Although there is evidence suggesting a reduction in muscle stiffness, this finding does not appear to be consistent across the literature. Furthermore, no studies have been identified that evaluated the effects of FR on the recovery of fascial and tendinous tissues. Regarding functional properties, although FR application may promote improved recovery of DOMS, ROM, vertical jump performance, and muscle strength, contradictory findings have been reported. Therefore, the aim of the present study is to investigate the effects of FR on the recovery of musculotendinous and functional properties of plantar flexors in healthy individuals. A total of 69 healthy male participants, aged between 18 and 40 years, will be included in the study. Participants will undergo an EIMD protocol using an isokinetic dynamometer and will be randomly assigned to either the FR (self-myofascial release with FR: 3 sets of 30 s) or a control group (CON; rest for 90 s). The mechanical properties of the myofascial tissues of the triceps surae and the Achilles tendon (AT) will be assessed using shear wave elastography, while echo intensity (EI) of the triceps surae will be obtained through grayscale analysis of ultrasound (US) images. DOMS will be assessed using a visual analog scale. Maximum dorsiflexion ROM, peak torque production (isometric and isokinetic), and rate of torque development of the plantar flexors will be evaluated using the isokinetic dynamometer. Drop jump performance will be assessed using a force platform. Ultrasound imaging will also be used to determine cross-sectional area, resting length, and deformation of the AT during maximal voluntary isometric contractions. Based on these data, force-deformation and stress-strain relationships of the AT will be determined. Assessments will be conducted before (Pre-1 and Pre-EIMD), immediately after the EIMD protocol (Post-EIMD), and at 24 h (Post-24h), 48 h (Post-48h), and 72 h (Post-72h) following the interventions (FR or CON). Descriptive statistics (mean, standard deviation, and standard error) will be used to present the results. Reliability of US measurements, as well as data normality and sphericity, will be assessed. A two-way ANOVA (group × time) will be used for comparisons, followed by Bonferroni post hoc tests to identify differences. Additionally, effect sizes will be calculated for each intervention, and correlation analyses will be performed to examine the influence of adipose tissue thickness on the evaluated parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedStudy Start
First participant enrolled
August 24, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2026
Study Completion
Last participant's last visit for all outcomes
October 8, 2026
August 12, 2026
August 1, 2026
2 months
April 14, 2026
August 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
delayed-onset muscle soreness (DOMS) assessed by the 10cm visual analog scale (VAS)
Baseline (before the muscle damage protocol), immediately after the muscle damage protocol, and 24 hours, 48 hours, and 72 hours after the muscle damage protocol.
Maximum voluntary isometric contraction (MVIC)
Baseline (before the muscle damage protocol), immediately after the muscle damage protocol, and 24 hours, 48 hours, and 72 hours after the muscle damage protocol.
Secondary Outcomes (7)
Range of motion (ROM)
Baseline (before the muscle damage protocol), immediately after the muscle damage protocol, and 24 hours, 48 hours, and 72 hours after the muscle damage protocol.
Torque (concentric and eccentric)
Baseline (before the muscle damage protocol), immediately after the muscle damage protocol, and 24 hours, 48 hours, and 72 hours after the muscle damage protocol.
Single-leg drop jump height
Baseline (before the muscle damage protocol), immediately after the muscle damage protocol, and 24 hours, 48 hours, and 72 hours after the muscle damage protocol.
echo intensity (EI)
Baseline (before the muscle damage protocol), immediately after the muscle damage protocol, and 24 hours, 48 hours, and 72 hours after the muscle damage protocol.
pennation angle (PA)
Baseline (before the muscle damage protocol), immediately after the muscle damage protocol, and 24 hours, 48 hours, and 72 hours after the muscle damage protocol.
- +2 more secondary outcomes
Study Arms (2)
Control
NO INTERVENTIONFoam rolling
EXPERIMENTALInterventions
Participants will undergo an exercise Induced muscle damage protocol (4 sets of 25 maximal eccentric contractions) using an isokinetic dynamometer and will be assigned to the Foam Rolling (FR) group (self-myofascial release with FR: 3 sets of 30 s).
Eligibility Criteria
You may qualify if:
- Male individuals (aged 18-40 years);
- Who had not engaged in any form of lower limb strength training and;
- Had no prior experience with FR participated in this study.
You may not qualify if:
- Presence of musculoskeletal injuries in the lower limbs;
- Contraindications for performing maximal tests (including cardiovascular, respiratory, musculoskeletal or neurological conditions);
- Engagement in high-intensity physical activity within 72 hours prior to assessments;
- Current usage of dietary or anabolic supplements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Esefid/Ufrgs
Porto Alegre, Rio Grande do Sul, 90690-200, Brazil
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 14, 2026
First Posted
August 12, 2026
Study Start (Estimated)
August 24, 2026
Primary Completion (Estimated)
October 8, 2026
Study Completion (Estimated)
October 8, 2026
Last Updated
August 12, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share